🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 12 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/03/2017 | 33,35 | 33,73 | 32,29 | 32,73 | -2,09% | 4,32% | 1.427.900 |
| 08/03/2017 | 33,00 | 34,25 | 32,63 | 33,43 | +3,53% | 4,91% | 1.996.200 |
| 07/03/2017 | 32,81 | 33,34 | 32,14 | 32,29 | -3,24% | 3,66% | 1.390.400 |
| 06/03/2017 | 34,10 | 34,39 | 33,13 | 33,37 | -2,97% | 3,70% | 1.698.000 |
| 03/03/2017 | 33,05 | 34,85 | 32,76 | 34,39 | +5,39% | 6,32% | 3.624.800 |
| 02/03/2017 | 32,00 | 34,33 | 31,65 | 32,63 | +7,41% | 8,38% | 7.407.800 |
| 01/03/2017 | 29,65 | 31,91 | 28,50 | 30,38 | -2,35% | 11,50% | 8.329.300 |
| 28/02/2017 | 32,99 | 33,65 | 31,00 | 31,11 | -4,89% | 8,03% | 4.143.900 |
| 27/02/2017 | 32,06 | 32,82 | 31,22 | 32,71 | +2,15% | 4,99% | 2.920.800 |
| 24/02/2017 | 30,08 | 32,09 | 29,70 | 32,02 | +6,20% | 7,95% | 2.909.400 |
| 23/02/2017 | 30,60 | 31,29 | 29,60 | 30,15 | -0,76% | 5,52% | 2.207.000 |
| 22/02/2017 | 28,61 | 30,60 | 28,31 | 30,38 | +5,93% | 8,00% | 2.915.100 |
| 21/02/2017 | 28,88 | 29,00 | 28,08 | 28,68 | +1,41% | 3,19% | 2.139.800 |
| 17/02/2017 | 27,80 | 28,35 | 27,21 | 28,28 | +1,11% | 4,10% | 1.406.700 |
| 16/02/2017 | 27,93 | 28,35 | 26,96 | 27,97 | +0,21% | 4,98% | 1.621.400 |
| 15/02/2017 | 28,48 | 28,83 | 27,63 | 27,91 | -1,27% | 4,21% | 1.619.100 |
| 14/02/2017 | 27,80 | 28,95 | 27,75 | 28,27 | +2,17% | 4,32% | 1.922.500 |
| 13/02/2017 | 27,81 | 27,85 | 26,26 | 27,67 | -0,57% | 5,72% | 3.238.400 |
| 10/02/2017 | 29,43 | 29,44 | 27,83 | 27,83 | -5,15% | 5,47% | 2.045.800 |
| 09/02/2017 | 29,50 | 29,82 | 28,61 | 29,34 | +0,27% | 4,10% | 2.078.100 |
| 08/02/2017 | 29,38 | 29,72 | 28,68 | 29,26 | +0,31% | 3,54% | 1.455.700 |
| 07/02/2017 | 29,19 | 30,90 | 28,74 | 29,17 | +0,34% | 7,40% | 3.664.000 |
| 06/02/2017 | 29,30 | 29,40 | 28,62 | 29,07 | -0,89% | 2,66% | 1.390.200 |
| 03/02/2017 | 29,15 | 29,36 | 28,82 | 29,33 | +1,45% | 1,85% | 1.361.400 |
| 02/02/2017 | 28,91 | 29,47 | 28,40 | 28,91 | -0,65% | 3,70% | 1.791.300 |
| 01/02/2017 | 30,51 | 30,80 | 28,58 | 29,10 | -6,31% | 7,28% | 3.856.900 |
| 31/01/2017 | 28,72 | 31,29 | 28,27 | 31,06 | +7,21% | 10,52% | 3.766.700 |
| 30/01/2017 | 30,62 | 30,62 | 28,75 | 28,97 | -6,03% | 6,11% | 2.288.100 |
| 27/01/2017 | 30,00 | 31,04 | 29,39 | 30,83 | +2,60% | 5,50% | 1.911.200 |
| 26/01/2017 | 30,23 | 31,11 | 29,84 | 30,05 | -0,66% | 4,20% | 1.272.300 |